Back to Authors

Xu, David N.

0000-0003-3649-4746

Mayo Clinic

Mid Atlantic Retina

Citations 1

VITREORETINAL OUTCOMES FOLLOWING SECONDARY INTRAOCULAR LENS IMPLANTATION WITH PARS PLANA VITRECTOMY
Kaufmann, Gabriel T. , Gupta, Omesh P. , Yu, Julia , Lee, Crystal Y., Achuck, Kathryn, Hsu, Jason C. , Regillo, Carl D. , Garg, Sunir J. , Klufas, Michael A. , Mehta, Sonia , Cohen, Michael N. , Yonekawa, Yoshihiro , Starr, Matthew R , Nguyen, Michael K. , Achuck, Kathryn, Hsu, Jason, Ho, Allen C. , Xu, David N. , Kuriyan, Ajay E. , Starr, Matthew R.

Retina | May 7, 2024 | Volume: 44 | Issue: 8 | Pages: 1337-1343

10.1097/iae.0000000000004139 Get It

Background: Retrospective cohort study of 561 adult patients undergoing secondary intraocular lens (IOL) implantation by vitreoretinal surgeons at a single institution from April 2015 to December 2020. Methods: Patient historical factors, intraoperative/postoperative complications, and outcomes of IOL type (anterior chamber IOL versus scleral sutured IOL versus scleral fixated IOL versus. sulcus) were assessed. Primary outcomes were rates of postoperative retinal tears and rhegmatogenous retinal detachment. Secondary outcomes were rates of intraoperative endolaser, intraoperative retinal tear, and further IOL surgery. Results: The incidence of intraoperative retinal tears was 7.3% and not significantly different between techniques. Rates of intraoperative endolaser use were 17.5% among all techniques and not significantly different between techniques. Rates of postoperative retinal tear were low (0%–2.7%). Rates of postoperative rhegmatogenous retinal detachment were not significantly different between techniques (anterior chamber IOL 9/198 [4.5%], SFIOL 1/54 [1.9%], scleral sutured IOL 14/274 [5.1%], sulcus 2/35 [5.7%], total 26/561 [4.6%], P = 0.79). Rates of repeat IOL surgery trended higher in sulcus lenses (anterior chamber IOL 5/198 [2.5%], SFIOL 4/54 [7.4%], scleral sutured IOL 16/274 [5.8%], sulcus 5/35 [14.3%], total 30/561 [5.3%], P = 0.12). Conclusion: Intraoperative endolaser use and intraoperative retinal tear are not uncommon in secondary IOL surgery and underscore the importance of careful vitreoretinal management among these patients.